AI assistant
IMUGENE LIMITED — Major Shareholding Notification 2008
Feb 3, 2008
65124_rns_2008-02-03_a3e91bd2-0b20-412b-9114-2b47dd5fc69c.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
603 page 1/2
Form 603
Corporations Act 2001
Section 671B
Notice of initial substantial holder
To: Imugene Limited ACN 009 179 551
1. Details of substantial holder (1)
Name Dr Warwick Andrew Lamb
ACN/ARSN (if applicable) n/a
The holder became a substantial holder on 31/01/08
2. Details of voting power
The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:
| C | lass of securities (4) | lass of securities (4) | N | umber of securities | Person's votes (5) | Voting power (6) |
|---|---|---|---|---|---|---|
| O | rdinary Shares | 7,520,002 | 7,520,002 | 5.2% | ||
3. Details of relevant interests
The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:
| H | older of relevant interest | Nature of relevant interest (7) | Class and number of securities |
|---|---|---|---|
| H | ELD DIRECTLY | RegisteredHolder | 7,245,002Ordinary Shares |
| VETSPECPTY LTD | RegisteredHolder | 275,000 Ordinary Shares |
4. Details of present registered holders
The persons registered as holders of the securities referred to in paragraph 3 above are as follows:
| Holder of relevant | Registered holder of | Class and number of | |
|---|---|---|---|
| interest | securities | Person entitled to be registered as holder (8) | securities |
| Dr Warwick Andrew | Dr Warwick Andrew | ||
| Lamb | Lamb | Dr Warwick Andrew Lamb | 7,245,002Ordinary Shares |
| VETSPECPTY LTD | VETSPECPTY LTD | VETSPECPTY LTD | 275,000 Ordinary Shares |
603 page 2/2
5. Consideration
The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:
| 5. Consideration | 5. Consideration | |||||
|---|---|---|---|---|---|---|
| The consideration paid for each relev | ant interest referred to in paragraph 3 abo | ve, and acquired in the four months prior to | ||||
| that the substantial holder became a s | ubstantial holder is as follows: | |||||
| Holder ofrelevantinterest | Date of acquisition | Consideration (9) | Classnumbsecur | ander ofities | ||
| Cash | N | on-cash | ||||
| 23 January2008 | $86,100 | n/a | 615,001 Fullypaid ordinaryshares | |||
| 23 January2008 | $3,500 | n/a | 25,000 Fullypaid ordinaryshares | |||
| 31January2008 | $67,200 | n/a | 480,000 Fullypaid ordinaryshares |
6. Associates
The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:
| Name and ACN/ARSN (if | |
|---|---|
| applicable) | Nature of association |
| VETSPECPTY LTD | ControlledBody Corporate |
7. Addresses
The addresses of persons named in this form are as follows:
| Name | Address |
|---|---|
| Dr Warwick Andrew Lamb | Level 1,14-20Delhi Road,NORTH RYDE NSW 2113 |
| VetspecPtyLtd | Level 1,14-20Delhi Road,NORTH RYDE NSW 2113 |
Signature
print Registered holder and name Warwick Lamb capacity Director sign date 4 / 2 / 08 here